High Purity Recombinant EGF Factor Non - Animal Component For Xeno - Free Medium

High Purity Recombinant Epidermal Growth Factors EGF Non - Animal Component For Xeno - Free Medium​

Description

Xeno-free medium, many commercial companies to develop xeno-free medium is based on the production of recombinant drug safety considerations, the addition of components in the medium no different sources, the required protein from the recombinant protein or protein hydrolyzate, these groups Min can protect the cell growth and proliferation needs. rhEGF can meet the requirement without heterologous medium.

Quick detail

1. CAS No.: 62253-63-8
2. Other Names: rhEGF, Recombinant epidermal growth factor, recombinant EGF, rEGF, EGF
3. EINECS No.: 263-468-7
4. Place of Origin: Wuhan China (Mainland)
5. Brand Name: Oryzogen
6. Model Number: HYC020M01
7. Purity: Greater than 98 % as determined by SDS-PAGE
8. Storage and Handling: Stored at temperatures -20℃ for 24 months

Physiological and Biochemical Properties of our rhEGF and rEGF(E.coli)

Advantages

1. Wuhan Healthgen Biotechnology Corp. is a private company founded in 2006. We specialize in molecular pharmaceutical technology research and high-tech innovation-oriented product development, which is developing, manufacturing and marketing a series of recombinant proteins and growth factors by rice endosperm platform. We have 400 square meters of research center, in which 30% of the research personnels have doctoral degree and major in different directions of the research and development. Healthgen Biotech has strong capability in developing a series of biological products.

2. Healthgen Biotech recombinant Human Epidermal Growth Factor (rhEGF) has excellent batch consistency. Using the world's advanced facility and top production proceeding to extract and purify the rhEGF, Healthgen Biotech can ensure the excellent consistency of rhEGF from different batches.

Supplemental Description 

Achievement and Honor

Healthgen Biotech obtained a number of patented technologies with independent intellectual property rights, including applied 9 national patents and 6 authorized patents, applied 7 international patents and 3 authorized patents. The international patents cover to United States, Japan, Europe and Canada. Moreover, two patents were authorized both by the Republic of South Africa and the United States. Based on rice endosperm specific expression technical platform-Oryz^HiExp, Healthgen Biotech, aim at the international forefront, takes the market as the orientation and enhances biotechnology innovation and engineering research, has won numerous awards.

Scientific Research Projects:

Major projects for New Drug Discovery, 3 projects of "Major projects of new varieties of genetically modified organisms” of the Ministry of Agriculture, National Ministry of Science and high Technology “863 plan”, National Ministry of Science and Technology Innovation fund, Pilot development of strategic emerging industries project

Talents Scheme:

“Thousand Talents program” of the National Central Organization Department, "Hundred Talents Program" of the Organization Department of Hubei Province, "3551 talents program” of the East Lake high-technology development zone , Top 10 "Venture Eagle" entrepreneurs.

Research Centers and Awards:

Wuhan National Biological Industry Base protein purification center, Hubei Molecular Biopharmaceutical Engineering Research Center, 2013 National Science and Technology Invention Award, 2012 Hubei Provincial Science and Technology Invention Award, 2013 China Patent Excellence Award, High-tech enterprise, Agricultural science and technology enterprise, Patent advantage enterprise.